U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Nucleic Acid
Created
by admin
on Sat Dec 16 18:42:32 GMT 2023
Edited
by admin
on Sat Dec 16 18:42:32 GMT 2023
Nucleic Acid Type APTAMER
Nucleic Acid Subtype
Sequence Type COMPLETE
Record UNII
668URB6QJV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Eldocasiran
INN  
Official Name English
eldocasiran [INN]
Common Name English
Code System Code Type Description
FDA UNII
668URB6QJV
Created by admin on Sat Dec 16 18:42:32 GMT 2023 , Edited by admin on Sat Dec 16 18:42:32 GMT 2023
PRIMARY
NCI_THESAURUS
C190370
Created by admin on Sat Dec 16 18:42:32 GMT 2023 , Edited by admin on Sat Dec 16 18:42:32 GMT 2023
PRIMARY
INN
12151
Created by admin on Sat Dec 16 18:42:32 GMT 2023 , Edited by admin on Sat Dec 16 18:42:32 GMT 2023
PRIMARY
CAS
2615098-65-0
Created by admin on Sat Dec 16 18:42:32 GMT 2023 , Edited by admin on Sat Dec 16 18:42:32 GMT 2023
PRIMARY
Sugar Site Range Site Count
Deoxyribose (DNA) 1_21-1_22 2 / 44
D-Ribose (RNA) 1_3-1_18;2_1-2_22 38 / 44
2'-O-Methyl-Ribose 1_1-1_2;1_19-1_20 4 / 44
Linkage Site Range Site Count
Phosphate 1_2-1_22;2_2-2_22 42 / 42
Related Record Type Details
TARGET -> INHIBITOR
Notably, the antitumor effect of miR-193a-3p transfection in glioma cells may be due to the miR-193a-3p–induced inhibition of AKT2 expression caused by the suppression of ALKBH5 expression.
PRECLINICAL
TARGET->INHIBITOR OF EXPRESSION
PRECLINICAL
Related Record Type Details
ACTIVE MOIETY